FDA Releases Initial Guidelines for Cannabis-Derived Drugs
5 years ago 1 min read
The Food and Drug Administration released a draft of rules that companies should follow to develop cannabis-derived drugs — a new category that has exploded with few federal laws to govern it.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push